Curtis Hayden
Bloomington, ILNPI 1760588248
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.9% of the total across 180 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 11.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,812 and has fallen 93.2% since, to $123 in 2024.
Across 180 payments — averaging $26.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$568
- Lundbeck LLC$350
- AbbVie$337
- Jazz Pharmaceuticals Inc.$324
- Mallinckrodt Enterprises LLC$306
- Mallinckrodt Hospital Products Inc.$304
- plus $3K from 23 others
What the payments were for
- Food & beverage$4,65498%
- Education$992%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 57 | $568 |
| Lundbeck LLC | 5 | $350 |
| AbbVie(2 entities) | 21 | $337 |
| Jazz Pharmaceuticals Inc. | 8 | $324 |
| Mallinckrodt Enterprises LLC | 9 | $306 |
| Mallinckrodt Hospital Products Inc. | 10 | $304 |
| Biohaven Pharmaceuticals, Inc. | 6 | $249 |
| Teva Pharmaceuticals USA, Inc. | 11 | $249 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $220 |
| Neurocrine Biosciences, Inc. | 9 | $205 |
| Amgen | 5 | $185 |
| EMD Serono, Inc. | 3 | $176 |
| AstraZeneca | 2 | $159 |
| SK Life Science, Inc. | 4 | $148 |
| Johnson & Johnson | 2 | $145 |
| Sanofi | 4 | $144 |
| Acadia Pharmaceuticals Inc | 2 | $120 |
| Lilly USA, LLC | 4 | $119 |
| Globus Medical | 1 | $115 |
| Grifols USA, LLC | 1 | $89 |
| Livanova USA, Inc. | 4 | $65 |
| Biogen | 2 | $41 |
| E.r. Squibb & Sons, L.L.C. | 2 | $34 |
| Amneal Pharmaceuticals LLC | 1 | $22 |
| Corium, LLC | 1 | $20 |
| Upsher-smith Laboratories LLC | 1 | $18 |
| Genentech USA, Inc. | 1 | $14 |
| Neurelis, Inc. | 1 | $14 |
| Assertio Therapeutics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.